Back to Search
Start Over
High-Dose Methotrexate, Ibrutinib and Temozolomide (MIT) for the Treatment of Newly Diagnosed Primary Central Nervous System Lymphoma: A Multi-Center Prospective Phase II Study
- Source :
- Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p3086-3086, 1p
- Publication Year :
- 2023
-
Abstract
- Abstract
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 142
- Issue :
- 1, Number 1 Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs64701142
- Full Text :
- https://doi.org/10.1182/blood-2023-185212